BEACONLIGHT CAPITAL, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
BEACONLIGHT CAPITAL, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2022$2,506,000
-48.3%
39,626
-42.3%
0.79%
-62.5%
Q3 2021$4,848,000
-21.4%
68,682
-25.8%
2.12%
-3.9%
Q2 2021$6,168,000
-64.5%
92,550
-40.8%
2.20%
-21.3%
Q1 2021$17,361,000
+2.2%
156,395
+9.4%
2.80%
-45.7%
Q4 2020$16,981,000
+109.2%
142,994
+53.7%
5.15%
+77.4%
Q3 2020$8,118,000
-4.6%
93,040
-2.1%
2.90%
+2.3%
Q2 2020$8,511,000
-61.8%
95,033
-57.5%
2.84%
-52.1%
Q1 2020$22,285,000
+315.6%
223,613
+142.2%
5.92%
+201.1%
Q4 2017$5,362,000
-7.5%
92,317
-28.6%
1.97%
-35.7%
Q3 2017$5,798,000129,2173.06%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders